OPA1 and diabetes mellitus: In summary, OPA1, MFN1, MFN2 mRNA and protein expression analysis shows that mitochondrial fusion dysfunction occurs during the development of diabetes, resulting in abnormal mitochondrial morphology, and ShenQiWan can alleviate the renal injury by stabilizing the mitochondrial fusion process.